Phound Becomes First Phone Service to Bring Smart, Trusted Conversations to Everyone, All Powered by Magnum AI
LONG BEACH, Calif., June 9, 2025 /PRNewswire/ -- Phound, the trusted app for secure calls and messaging, features Magnum AI, the built-in assistant that quietly transforms everyday conversations into clear, trusted takeaways.
From business calls and team meetings to quick chats with clients, Magnum AI automatically helps users remember what was said, who said it, and what needs to happen next. It's now available to everyone using Phound with a Premium subscription.
No notes? No problem. Magnum creates a smart summary for every call, including key points, decisions, and next steps.
Know what matters. Every conversation is saved as a trusted record, so you can search, share, or follow up with confidence.
Your invisible teammate. Magnum AI, after being invited to the call, works in the background—no extra steps, no interruptions, just results.
Phound is also the first consumer and business phone service to bring this level of conversation intelligence to general users, all powered by CarrierX's vCon platform for virtualized conversations. vCons are structured, secure digital records that organize calls and meetings into searchable, trustworthy memories. It's a new way to communicate, with built-in clarity and accountability. By leveraging CarrierX's Zero-Hop Connect to all three major U.S. mobile operators and HD audio technology, the call's audio is captured with the least delay and the highest voice quality today.
"People are overwhelmed by meetings, messages, and follow-ups," said Dave Erickson, co-founder of Phound. "Magnum AI is here to change that. It doesn't just listen, it helps you move forward. And with vCons at the center of it, you always have a trusted version of what really happened."
Magnum AI marks a turning point for everyday communication. It combines AI memory with verified trust, something previously only available to large enterprise systems.
"Phound continues democratizing calling, providing individuals and businesses with the most modern, trusted, and most feature-rich service available that offers free calling and texting anywhere," added Erickson.
Phound is now the first platform where individuals, small businesses, and teams can experience the benefits of vCons without needing IT departments or special training.
See it in action:How to Use Phound's AI Assistant for Smarter, Verified Communication
To try Phound, experience Magnum AI, and see how smart conversations are becoming secure, clear, and action-ready, visit www.phound.app.
About PhoundPhound is a trusted communication service that combines advanced contact management, government-backed identity verification, and AI-powered spam-blocking to transform how people connect. Designed to meet the demands of today's hybrid world, Phound empowers users with tools to manage their digital personas, protect their privacy, and build authentic relationships. By prioritizing trust and security, Phound is redefining communication for individuals and businesses alike.
Visit phound.app to learn more.
Contact: Phound Media RelationsAndy AbramsonEmail: 396389@email4pr.com Phone: 1-213-322-1200
View original content to download multimedia:https://www.prnewswire.com/news-releases/phound-becomes-first-phone-service-to-bring-smart-trusted-conversations-to-everyone-all-powered-by-magnum-ai-302475824.html
SOURCE Phound
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
2024 Cell and Gene Therapy Market Set for Breakthrough Growth, Says BCC Research
"Comprehensive Review Highlights Market Growth, Innovation, and Investment Trends Driving the Future of Cell and Gene Therapy Tools, Biomanufacturing, and Gene Synthesis" BOSTON, June 20, 2025 /PRNewswire/ -- BCC Research announces the release of its "2024 Cell and Gene: Research Review," which forecasts strong and steady growth across several key areas of the cell and gene therapy (CGT) industry. This momentum is fueled by ongoing innovation, growing investments, and rising global demand for cutting-edge therapeutic solutions. Key Highlights: • Cell and Gene Therapy Tools, and Reagents: Global Markets: The market is projected to grow from $10.0 billion in 2024 to $16.7 billion by the end of 2029. Compound Annual Growth Rate (CAGR): 10.8%. • Cell Therapy Biomanufacturing: Global Markets: The market is projected to grow from $9.7 billion in 2024 to $16.7 billion by the end of 2029. CAGR: 11.5%. • Gene Synthesis: Technologies and Global Markets: The market is projected to grow from $2.0 billion in 2023 to $4.1 billion by the end of 2028. CAGR: 15.8%. Research Coverage and Insights:This Research Review provides a clear snapshot of the fast-moving cell and gene therapy (CGT) industry. It looks at how these technologies are being used across the entire development pipeline from early research to clinical use and large-scale manufacturing, while also examining the key trends, opportunities, and challenges shaping the market. Key insights include:Broad Application Scope: CGT technologies are being applied in preclinical studies, clinical trials, therapeutic production, viral vector development, and personalized medicine. Investment-Driven Growth: A significant rise in funding and investment is accelerating innovation and expanding the CGT pipeline. Innovation at the Core: Breakthroughs in gene editing, cell modification, and biomanufacturing are pushing the boundaries of what is possible in modern medicine. Cost Challenges: Despite strong momentum, the high cost of therapy development continues to be a limiting factor for broader market adoption. Research Summary:The 2024 Cell and Gene: Research Review exemplifies the type of quantitative market data, analysis, and guidance that BCC Research has provided since 1971. This research review includes highlights and excerpts from the following reports published by BCC Research in 2024: • BIO208C Cell and Gene Therapy Tools, and Reagents: Global Markets. • BIO211B Cell Therapy Biomanufacturing: Global Markets. • BIO251A Gene Synthesis: Technologies and Global Markets. • BIO258A Global Automated and Closed Cell Therapy Market. • BIO225B Global Market for Cell and Gene Therapy. • BIO256A Global Live Cell Imaging Market. • BIO257A Global Single-cell Technologies Market. After accessing this Research Review and benefiting from its insight, we encourage you to explore the full portfolio of market research reports for a deeper understanding of each topic. BCC Research remains your trusted partner in market intelligence, and we are committed to supporting your future insights and decisions. Navigate Uncertainty with ConfidenceIn times of rapid change and uncertainty, having the right insights can make all the difference. At BCC Research, we are here to support innovation and help you stay ahead. Our custom research reports provide a comprehensive, 360-degree view of your market landscape, giving you the clarity you need to make informed decisions. We believe that timely, expert market intelligence should be accessible to all. That is why, for a limited time, we are offering 30% off the price of any BCC Research report to help more organizations gain access to our latest data and insights. For further information on any of the reports or to make a purchase, contact us at info@ About BCC Research BCC Research market research reports provide objective, unbiased measurement, and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. Contact Us Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USAEmail: info@ +1 781-489-7301For media inquiries, email press@ or visit our media page for access to our market research data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. Logo: View original content to download multimedia: SOURCE BCC Research LLC Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
Natural Carotenoids Market Poised to Reach $3.3 Billion by 2035, Growing at a CAGR of 8.7% from 2025--Exclusive Report by Meticulous Research®
Market valued at $1.35 billion in 2024 set to grow at 8.7% CAGR through 2035, driven by surging demand for natural food colors and functional ingredients Comprehensive 224-page report analyzes market dynamics, competitive landscape, and growth opportunities across multiple industries REDDING, Calif., June 20, 2025 /PRNewswire/ -- According to a new market research report titled "Natural Carotenoids Market by Type (Astaxanthin, Lutein, Beta-Carotene), Source (Plant, Algae), Application (Dietary Supplements, Food & Beverage, Cosmetics), and Region – Global Forecast to 2035", the global natural carotenoids market is expected to be valued at $1.35 billion in 2024 and reach approximately $3.3 billion by 2035. This represents a CAGR of 8.7% during the forecast period of 2025–2035. Market Expansion Driven by Consumer Health Consciousness The growth of natural carotenoids market is primarily fueled by the growing consumer preference for natural food colors, rising health consciousness, and increasing demand for functional foods. The shift away from synthetic additives toward natural alternatives is reshaping multiple industries, from food and beverage to cosmetics and pharmaceuticals. "The natural carotenoids market is at an inflection point, with consumers increasingly demanding transparency and natural ingredients in their products," the report notes. "This trend is being supported by regulatory frameworks that favor natural additives and technological advances in extraction and processing methods." For more comprehensive insights, download the FREE report sample: Key Market Segments Show Strong Growth Potential The report's detailed segmentation analysis reveals several high-growth areas: By Type: While beta-carotene maintains the largest market share due to its widespread applications, astaxanthin is emerging as the fastest-growing segment, driven by applications in aquaculture feed, dietary supplements for eye health, and premium cosmetic formulations. By Form: The powder segment dominates the market due to stability and cost-effectiveness, but liquid formulations are experiencing the fastest growth rate, supported by demand for ready-to-use products and better bioavailability. By Source: Plant-sourced carotenoids hold the largest market share, while algae-sourced variants are experiencing rapid growth due to sustainable production methods and high purity levels. By Application: The food and beverage sector represents the largest application segment, but dietary supplements are showing the fastest growth rate, reflecting increasing health awareness and an aging global population. Get Insightful Data on Regions, Market Segments, Customer Landscape, and Top Companies (Charts, Tables, Figures and More) - Regional Market Dynamics North America leads the global market, supported by advanced food processing infrastructure, high consumer awareness, and strong regulatory frameworks. Europe follows as the second-largest market, driven by stringent regulations favoring natural ingredients. However, the Asia-Pacific region is witnessing the fastest growth rate, propelled by expanding food processing industries, growing middle-class populations, and increasing adoption of functional foods. Innovation and Technology Driving Market Evolution The report highlights significant technological advancements reshaping the industry, including microencapsulation and nano-delivery systems, biotechnology and fermentation-based production methods, and novel extraction technologies. These innovations are addressing traditional challenges such as stability, shelf-life, and production costs while opening new application possibilities. Addressing Market Challenges Despite strong growth prospects, the market faces several challenges including high production and processing costs, stability and shelf-life issues, limited availability of raw materials, and complex regulatory compliance requirements across different regions. However, emerging biotechnology solutions and sustainable sourcing practices are providing pathways to overcome these obstacles. Request a customized research analysis tailored to your specific requirements: Competitive Landscape Features Diverse Player Base The market features a diverse competitive environment comprising established chemical companies, biotechnology specialists, agricultural processors, and innovative extraction technology providers. Key market players include Koninklijke DSM N.V., Sensient Technologies Corporation, Archer Daniels Midland Company, BASF SE, and Kemin Industries, Inc., among others. Leading companies are focusing on integrated solutions that combine advanced extraction technologies with comprehensive application support while addressing sustainability challenges across various regions. Growth Opportunities Abound The report identifies numerous high-growth opportunities, including expansion in emerging markets, development of biotechnology and fermentation-based production methods, advancement of novel extraction and encapsulation technologies, and growing applications in the aquaculture industry. Report Specifications Pages: 224 Format: PDF & Excel Forecast Period: 2025–2035 Base Year: 2024 Geographic Coverage: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa Key Segments: Type, Form, Source, Application Companies Profiled: 21+ leading market players Immediate Delivery Available | Buy this Research Report (Insights, Charts, Tables, Figures and More)- Related Industry Reports: Natural Food Colors Market by Size, Share, Forecasts, & Trends Analysis. Organic Food Market Size, Share, Trends & Growth 2032 Natural Sweeteners Market Size, Share & Growth Trends 2032 Natural Flavors Market Size & Share Forecast to 2032 About Meticulous Research We are a trusted research partner for leading businesses worldwide, empowering Fortune 500 organizations and emerging enterprises with market intelligence designed to drive revenue transformation and strategic growth. Our insights reveal future growth opportunities, equipping clients with a competitive edge through a versatile suite of research solutions—including syndicated reports, custom research, and direct analyst engagement. To find out more, visit or follow us on LinkedIn Contact: Mr. Khushal BombeMeticulous Market Research Pvt. Ltd.1267 Willis St, Ste 200 Redding,California, 96001, +1-646-781-8004Europe: +44-203-868-8738APAC: +91 744-7780008Email- sales@ Our Website: with us on LinkedIn- Source: Logo: View original content: SOURCE Meticulous Market Research Pvt. Ltd. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
SR BANCORP, INC. ANNOUNCES PAYMENT OF QUARTERLY CASH DIVIDEND OF $0.05 PER SHARE
BOUND BROOK, N.J., June 20, 2025 /PRNewswire/ -- SR Bancorp, Inc. (NASDAQ: SRBK), the holding company for Somerset Regal Bank, announced that its Board of Directors has declared the payment of a quarterly cash dividend. The dividend of $0.05 per share will be paid on July 15, 2025 to stockholders of record as of June 30, 2025. David Orbach, Executive Chairman of SR Bancorp, Inc said: "We are pleased to be in a strong financial position giving us the ability to pay a cash dividend." About SR Bancorp, Inc. SR Bancorp, Inc. is the holding company for Somerset Regal Bank, a full-service New Jersey commercial bank headquartered in Bound Brook, New Jersey that operates 14 branches in Essex, Hunterdon, Middlesex, Morris, Somerset and Union Counties, New Jersey. At March 31, 2025, Somerset Regal Bank had $1.07 billion in total assets, $780.8 million in net loans, $835.6 million in deposits and total equity of $195.1 million. Additional information about Somerset Regal Bank is available on its website, Forward Looking Statements Certain statements contained herein are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements, which are based on certain current assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of the words "may," "will," "should," "could," "would," "plan," "potential," "estimate," "project," "believe," "intend," "anticipate," "expect," "target" and similar expressions. Forward-looking statements are based on current beliefs and expectations of management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. Certain factors that could cause actual results to differ materially from expected results include increased competitive pressures, changes in the interest rate environment, inflation, general economic conditions or conditions within the securities markets, our ability to successfully integrate acquired operations and realize the expected level of synergies and cost savings, real estate market values in the Bank's lending area changes in the quality of our loan and security portfolios, increases in non-performing and classified loans, economic assumptions or changes in our methodology that may impact our allowance for credit losses calculation, changes in liquidity, including the size and composition of our deposit portfolio and the percentage of uninsured deposits in the portfolio, the availability of low-cost funding, monetary and fiscal policies of the U.S. Government including policies of the U.S. Treasury and the Board of Governors of the Federal Reserve System, a failure in or breach of the Company's operational or security systems or infrastructure, including cyber attacks, the failure to maintain current technologies, failure to retain or attract employees and legislative, accounting and regulatory changes that could adversely affect the business in which the Company and the Bank are engaged. Our actual future results may be materially different from the results indicated by these forward-looking statements. Except as required by applicable law or regulation, we do not undertake, and we specifically disclaim any obligation, to release publicly the results of any revisions that may be made to any forward-looking statement. View original content to download multimedia: SOURCE SR Bancorp, Inc. Sign in to access your portfolio
